Natera Inc. (NASDAQ:NTRA) shares rose slightly in premarket trading after a Delaware court awarded the company a 30% ongoing royalty on post-injunction revenues tied to its MRD-related patents.
The April 6, 2026 ruling builds on a prior jury award of a 20.5% royalty on pre-injunction sales, which remains unchanged. The court also upheld patent validity and infringement findings involving ArcherDx and Invitae.
Natera said the decision reinforces the strength of its MRD patent portfolio, part of its broader base of more than 650 issued or pending patents.
Technical Analysis
At $212.00, the stock is trading 7.1% above its 20-day simple moving average (SMA) of $198.02, suggesting a positive short-term trend. However, it is also trading 4.0% below its 100-day SMA of $219.58, indicating some intermediate-term weakness that traders should monitor.
The relative strength index (RSI) currently sits at 56.03, suggesting neutral momentum, while the moving average convergence divergence (MACD) indicates bullish sentiment, with the MACD line at 0.0940 …
This post was originally published here
